Transfection Technologies Market - Forecast(2021 - 2026)

Transfection Technologies Market size is estimated to be $832 Billion in 2019, growing at a CAGR of 8.8% during the forecast period 2020-2025. Transfection is the process in which molecules such as RNA, DNA, proteins, Oligonucleotides, are deliberately introduced into the recipient cell, integrating into the chromosomal DNA of the recipient cell causing a change in the properties of cell. In addition, the methods of transfection are usually transient transfection and stable transfection. Rising prevalence of cancer coupled with the growing population is a major factor driving the Transfection Technologies Market during the forecast period 2020-2025. Besides this, the growing cell-based research activities with application including spanning production of recombinant proteins and recombinant cell lines, Gene therapy, delivery of therapeutics and also Drug discovery is contributing to the market growth. Also, the developments by the major players is further driving the market growth. For instance, Polyplus-transfection SA is a leading biotechnology company that supports gene and cell therapy, biologics manufacturing and life-science research with innovative nucleic acid transfection solutions. Moreover, according to the National Cancer Institute in 2020 an estimated 1,809, 590 new cases of cancer will be diagnosed in the United States and 606, 520 people would die from the disease.

The report: “Transfection Technologies Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Transfection Technologies Market.

By Transfection Method- Cotransfection, Cationic Lipid Transfection, Electroporation, In Vivo Transfection and Others.

By Application- Gene silencing, protein production, Stem cell reprogramming and differentiation, stable cell line generation, virus production and Others.

By Geography- North America, Europe, Asia-Pacific and Rest-of-the-World.

By Transfection Method, the Transfection Technologies Market is segmented into Cotransfection, Cationic Lipid Transfection, Electroporation, in Vivo Transfection. Cotransfection segment held the largest market share in the year 2019 owing to increasing demand of virus production, protein-protein interaction studies, stable cell line generation, or simply addition of reporter DNA constructs to normalize experimental output. It is also expected to grow with the fastest CAGR of 9.4% during the forecast period 2020-2025. Moreover, cotransfection refers to the simultaneous transfection of two separate nucleic acids molecules including DNA and SiRNA. In addition, cotransfection is a common procedure for stable transfection. Besides this, recent developments by key companies is propelling the demand. For instance, Thermo fisher Scientific provides Lipofectamine 300 reagent leverages advanced lipid nanoparticle technology to enable superior transfection performance and reproducible results as it delivers exceptional transfection efficiency into the widest-range of difficult to transfect and common cell types with improved cell viability.

By Application, the Transfection Technologies Market is segmented into Gene Silencing, Protein Production, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation and Virus Production. Gene Silencing segment held the largest market share in the year 2019 owing to the increasing R&D activities. Moreover, gene silencing is the regulation of a gene expression in a cell to prevent a certain gene. In addition, gene silencing occurs in transcription or translation process and is often referred to as gene knockdown. Furthermore, Mirus TransIT Transfection Reagents for gene silencing plays an important role in molecular and cell biology which can be applied through transfection.

North America dominated the Transfection Technologies Market with a region share 43% in 2019 followed by Europe and APAC. Increasing adoption of advanced medical technology and rising development by companies operating transfection technologies is a major factor driving the Transfection Technologies market during the forecast period 2020-2025. Besides, the increasing number of people from suffering from different types of cancer is further contributing to the market growth. Furthermore, according to the National Cancer Institute as of January 2019, there was an estimated 16.9 million cancer survivors in the U.S. In addition, the number of cancer survivors is projected to increase to 22.2 million by 2030.

Rising Number of Breast Cancer Patients around the world is a major factor driving the Transfection Technologies Market during the forecast period 2020-2025. Increasing women population along with an increase in the breast cancer patients is propelling the market growth. Moreover, breast cancer affects one in every eight women and has been associated with higher rate of female’s mortality than any other cancer type. In addition, the chondromodulin a transfection technology was able to suppress tumor angiogenesis and growth in vivo eventually contributing to the market growth. Furthermore, according to the U.S Breast Cancer Statistics in 2020 an estimated 276,480 new cases of invasive breast cancer is expected to be diagnosed in women in the U.S., along with 48,530 new cases of non-invasive breast cancer.

Increase funding by companies is a major factor fueling the demand of Transfection Technologies Market during the forecast period 2020-2025. For instance, Polyplus-transfection SA which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics raised around euro 2.5million in its funding round. This round funding in new shareholders in Polypus transfection, AIRFI and Suddinova which has invested euro 1 million and 0.5 million respectively.

High Cost of Transfection Technology Instrument serves as a major setback for the growth of Transfection Technologies market during the forecast period 2020-2025. For instance, Mirus MIR 6006-TransIT-X2 dynamic delivery system cost $4,542.00. High cost has served a major factor restraining the market growth in the upcoming years.

Product Launches, Merger & Acquisition, joint ventures and R&D activities are key strategies adopted by the players in the Transfection Technologies Market. Transfection Technologies Market top 10 companies are Bio-Rad, Life technology, Lonza, Polyplus, Promega, Qiagen, Roche, Sigma Aldrich, Signagen and Thermofisher.